Our mission to CURE myeloid malignancies relies on collaboration between basic science researchers and clinical research. The Gehr CURES Program maintains a network of interdisciplinary relationships that foster the rapid movement of promising discoveries from the laboratory to the clinic where patients are most likely to benefit. We strive to remain focused on innovative strategies that have the potential to dramatically change the current approaches to myeloid malignancies, many of which haven’t changed in several decades.
We are constantly seeking to collaborate with innovative researchers worldwide. Here at home, we are grateful for the ongoing work of these and other collaborators: